C1AH34 Stock Overview
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 4/6 |
Cardinal Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$501.20 |
52 Week High | US$553.84 |
52 Week Low | US$399.40 |
Beta | 0.70 |
1 Month Change | -9.50% |
3 Month Change | -4.77% |
1 Year Change | n/a |
3 Year Change | 62.36% |
5 Year Change | n/a |
Change since IPO | 148.86% |
Recent News & Updates
Recent updates
Shareholder Returns
C1AH34 | BR Healthcare | BR Market | |
---|---|---|---|
7D | -9.5% | 3.6% | 1.4% |
1Y | n/a | 1.0% | 13.2% |
Return vs Industry: Insufficient data to determine how C1AH34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how C1AH34 performed against the BR Market.
Price Volatility
C1AH34 volatility | |
---|---|
C1AH34 Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 9.0% |
10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: C1AH34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine C1AH34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 47,520 | Jason Hollar | www.cardinalhealth.com |
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.
Cardinal Health, Inc. Fundamentals Summary
C1AH34 fundamental statistics | |
---|---|
Market cap | R$122.25b |
Earnings (TTM) | R$2.80b |
Revenue (TTM) | R$1.12t |
43.5x
P/E Ratio0.1x
P/S RatioIs C1AH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
C1AH34 income statement (TTM) | |
---|---|
Revenue | US$220.57b |
Cost of Revenue | US$213.18b |
Gross Profit | US$7.39b |
Other Expenses | US$6.84b |
Earnings | US$552.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.27 |
Gross Margin | 3.35% |
Net Profit Margin | 0.25% |
Debt/Equity Ratio | -179.5% |
How did C1AH34 perform over the long term?
See historical performance and comparison